Clinical trials
Phase 3 Granulomatosis with Polyangiitis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pennsylvania | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| Ottawa Hospital Research Institute | 1 |
| University of South Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Granulomatosis with Polyangiitis | 6 |
| Vasculitis | 6 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 5 |
| Microscopic Polyangiitis | 4 |
| Systemic Vasculitis | 2 |
| Autoimmune Diseases | 1 |
| Lung Diseases | 1 |
| Respiratory Tract Diseases | 1 |
| Vascular Diseases | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.